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Abstract
Anticancer activities of cinnamic acid derivatives include induction of apoptosis by irreversible DNA damage leading
to cell death. The present work aimed to compare the cytotoxic and genotoxic potential of cinnamic acid in
human melanoma cell line (HT-144) and human melanocyte cell line derived from blue nevus (NGM). Viability assay
showed that the IC50 for HT-144 cells was 2.4 mM, while NGM cells were more resistant to the treatment. The
growth inhibition was probably associated with DNA damage leading to DNA synthesis inhibition, as shown by
BrdU incorporation assay, induction of nuclear aberrations and then apoptosis. The frequency of cell death caused
by cinnamic acid was higher in HT-144 cells. Activated-caspase 3 staining showed apoptosis after 24 hours of
treatment with cinnamic acid 3.2 mM in HT-144 cells, but not in NGM. We observed microtubules disorganization
after cinnamic acid exposure, but this event and cell death seem to be independent according to M30 and tubulin
labeling. The frequency of micronucleated HT-144 cells was higher after treatment with cinnamic acid (0.4 and 3.2
mM) when compared to the controls. Cinnamic acid 3.2 mM also increased the frequency of micronucleated NGM
cells indicating genotoxic activity of the compound, but the effects were milder. Binucleation and multinucleation
counting showed similar results. We conclude that cinnamic acid has effective antiproliferative activity against
melanoma cells. However, the increased frequency of micronucleation in NGM cells warrants the possibility of
genotoxicity and needs further investigation.
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Introduction
Because there is no current effective treatment for meta-
static melanoma and the average survival time is only 6
to 10 months [1,2], one way to control for malignancy is
via prevention. In many cases, the term “prevention” is
used to chemopreventive suppression or reversal of pre-
malignant lesions even when the lesion is not completely
eliminated [3,4]. Several studies have shown that the
consumption of vegetables and fruits decreases the risk
of many malignancies [5-7] and can protect against can-
cers [8-10]. Natural products have been well recognized
as a source of drugs, and some plant extracts and com-
pounds that are isolated from medicinal plants have
been identified for their anti-cancer activities [11,12].
One anti-tumoral compound isolated from several
plant-derived products is cinnamic acid. Cinnamic acid
and its associated compounds can be found in coffee,
apples, citric fruits, vegetable oils, propolis and wine.
Cinnamic acid has a long history of human use as a
component of plant-derived scents and flavoring agent
[13]. Liu et al. [5] found that this compound induced
tumor cell differentiation by modulating the expression
of genes implicated in tumor metastasis and immuno-
genicity in cultured human melanoma cells.
Several researchers have also demonstrated the anti-
oxidant activity of caffeic acid and its derivatives [14,15],
which may be associated with cell death. Lee et al. [8]
demonstrated that natural antioxidant compounds in
diet, such as polyphenols in green tea, activate the
MAPK pathway. Moreover, at high concentrations, these
substances activate the caspase signaling cascade, which
induces apoptosis in normal cells [8].
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Lamartiniere et al. [16] showed that soy isoflavones
such as genistein (another polyphenolic compound) act
as chemopreventive agents against prostate and mam-
mary cancers. One of the chemopreventive mechanisms
against cancer is the induction of irreversible DNA dam-
age, which results in cell death via apoptosis [17]. Im-
paired function of p53 increases the probability of
proliferating cells with genetic abnormalities in some con-
ditions [18,19]. This is due to the activation of p53 in re-
sponse to unfavorable treatments, which results in genetic
abnormalities such as DNA breakages [20,21], disruption
of microtubules [22], lack of chromosome segregation at
mitosis [23] or the incorrect termination of cell division,
which can result in micronuclei formation [22].
The micronucleus test is widely used to detect
chromosomal aberrations because micronuclei can ori-
ginate from chromosomal fragments or disruptions in
the mitotic spindle [24,25]. This assay has been used to
evaluate the exposure levels of the human population to
mutagenic or genotoxic agents [26-30] as well as in cell
cultures to determine the mutagenic potential of drugs
and/or natural compounds [31-33].
The screening of new compounds with anti-microbial
and anti-inflammatory activities has resulted in the dis-
covery of anti-tumor and chemopreventive properties of
cinnamic acid and its derivatives [5,34-36]. Selective
cytotoxicity in tumor cells is an important role to be an-
alyzed to compare drug effects in cultured cells [37,38].
This study aimed to compare the cytotoxic and
genotoxic potential of cinnamic acid in both a human
melanocyte cell line of blue nevus and in cultured mel-
anoma human cells.
Materials and methods
Cell cultures
HT-144 cell line, derived from malignant cutaneous mel-
anoma, was obtained from American Type Culture Col-
lection (ATCC). NGM cell line, derived from melanocytes
of blue nevus, was obtained from Cell Bank of Rio de
Janeiro (Brazil). All cultured cells were maintained in
DMEM supplemented with 10% fetal bovine serum (FBS)
at 37°C in a humidified atmosphere of 5% CO2. The ex-
perimental protocols were approved by the Ethics Com-
mittee of the Institute of Biomedical Sciences, University
of São Paulo, Brazil (Protocol CEP-ICB n. 308/09).
Cinnamic acid
Cinnamic acid (CAS number 140-10-3) was obtained as
trans-cinnamic acid crystals, 99 + % (Sigma Aldrich
Chemical Company Inc.) and the solutions were pre-
pared by using 24 mg of the compound and 500 μL of
ethanol. Phosphate buffered saline (PBSA) was added to
complete 10 mL (final concentration at 16 mM). An
appropriate control with DMEM, 20% PBSA and 1%
ethanol was used.
Cytotoxicity assay
The MTT kit (Promega) was used to evaluate the cytotox-
icity. Briefly, 1 × 104 cells were seeded in each well
containing 100 μL of DMEM plus 10% of FBS in a 96-well
plate. After 24 h, various concentrations of cinnamic acid
were added. The control group received drug-free
medium. After 2 days, 15 μL of “Dye Solution” were added
to each well and the plates were incubated for additional
4 h. Then, 100 μL of “Solubilization/Stop Solution” were
added in each well and the optical density was measured
at 570 nm in an ELISA plate reader (BIO-RAD).
Propidium iodide staining for flow cytometry
NGM and HT-144 cells (3 × 105 cells/35 × 11 mm
dishes) were incubated for 24 h and then treated with
different concentrations of cinnamic acid. After 2 days
the cells were harvested and submitted to fixation with
75% of ice-cold methanol at 4°C for 1 h. Cells were then
washed with PBSA and suspended in propidium iodide
staining solution containing 200 μL of PBSA, 20 μL of
ribonuclease (10 mg/mL) and 20 μL of propidium iodide
(10 μg/mL). The cell suspensions were incubated for 1 h
at 4°C and 5,000 cells were analyzed by flow cytometry
in each group (EasyCyte MINI - Guava Technologies).
5-bromo-2-deoxyuridine incorporation
After incubation and treatment with cinnamic acid the
cells were submitted to BrdU (50 μM) (Sigma) incorpor-
ation for 30 minutes or 1 hour at 37°C. The samples
were washed with PBSA and fixed with ethanol/acetic
acid (3:1) for 15 minutes. The cells were incubated with
HCl 2 M for 30 minutes. Then, we added antibody anti-
BrdU (Sigma) (1:100) for 1 hour and, then, secondary
antibody FITC-conjugated for 30 minutes.
The cells were treated with ribonuclease (10 mg/mL)
and the nuclei were counterstained with propidium iod-
ide (10 μg/mL). We analyzed 1,000 cells/coverslips.
Activated-caspase 9 assay
NGM and HT-144 cells (3 × 105 cells/35 × 11 mm
dishes) were incubated for 24 h and subsequently
treated with different concentrations of cinnamic acid.
After 6, 12 or 24 hours the cells were harvested and
suspended at 1 × 105 cells/mL. Then, we added Caspase
Reagent Working Solution (protocol by Guava Technolo-
gies) into the cell suspension. After incubation for 1 hour
at 37°C we added 100 μL of 1× Apoptosis Wash Buffer in
each sample and centrifuged them at 300 G for 7 minutes.
The cells were resuspended in 200 μL of Caspase 7-AAD
Working Solution. The samples were analyzed by using a
flow cytometer (EasyCyte MINI - Guava Technologies).
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Immunoblots
The medium was removed after the treatments, and the
cells were washed with PBSA and lysed with RIPA buffer
[50 mM Tris–HCl (pH 7.5), 150 mM NaCl, 0.1% NP-40,
0.5% sodium deoxycholate, 1 mM EDTA and 2 mM
EGTA]. The lysates were centrifuged and the superna-
tants were collected. 30 μg of protein were fractionated
by SDS-PAGE on a 10% gel, and transferred to a PVDF
membrane (Amersham Bioscience). A blocking solution
(5% BSA (containing the phosphatase inhibitors NaF and
orthovanadate)) was added to the membrane for 1 hour.
The membrane was incubated overnight with an anti-
p53 or anti-phospho-p53 (Ser15) (Abcam Inc.) anti-
bodies diluted at 1:300. The immune complexes were
detected by using the ECL Western blotting detection
kit (Amersham Pharmacia). The ImageJ program was
used for the densitometric analyses.
M30, tubulin and actin staining
Cells were plated on coverslips (3 × 105 cells/35 × 11 mm
dishes). After 48 h of treatment, the cells were fixed with
formaldehyde 3.7% for 30 minutes, washed with PBSA
and treated with ribonuclease (10 mg/mL). To detect
cytokeratin 18 fragments we added M30 antibody
(FITC-conjugated) (CytoDEATH-Roche Labs) overnight
at room temperature. The cells were submitted to im-
munofluorescence with anti-α and β-tubulin (Sigma,
1:200) overnight at room temperature and secondary
antibody anti-mouse TRITC-conjugated.
In some cases, actin cytoskeleton was analyzed by using
phalloidin FITC-conjugated and anti-α and β-tubulin with
secondary antibody anti-mouse CY5-conjugated (Invitrogen,
1:200). Nuclei were counterstained with propidium iodide
(10 μg/mL).
The images were analyzed by Laser Scanning Confocal
Microscopy (Zeiss- LSM510) and we counted 1,000
cells/slide.
Nuclear abnormalities frequency
Cells were plated on coverslips (3 × 105 cells/35 × 11 mm
dishes), grown for 24 h and treated with cinnamic acid
at different concentrations. After 48 h of treatment, the
cells were fixed with formaldehyde 3.7% for 30 minutes,
treated with ribonuclease (10 mg/mL) for 30 minutes
and stained with propidium iodide (10 μg/mL) during
20 minutes. We analyzed 2,000 cells/coverslips and the
nuclear aberrations (micronucleation, binucleation and
multinucleation) were counted according to the classifi-
cation of Tolbert et al. [39], modified by Manelli-
Oliveira and Machado-Santelli [40].
Statistics
Statistical analysis on cell viability was achieved by χ2
tests to determine a statistical difference between the
treated cells and the control group for each concentra-
tion. Flow cytometry, BrdU incorporation, protein ex-
pression, M30 labeling and nuclear aberrations data
were analyzed by using the two way ANOVA test to ver-
ify a possible concentration-response or time-response
relationship. We also analyzed cell death by using Multi-
dimensional Nonlinear Descriptive Analysis (estimation
by using negative binomial model).
Results
Cell viability
A wide range of concentrations of cinnamic acid (0.0125
to 3.2 mM) was used to test the cytotoxic effects of the
compound on blue nevus-derived melanocytes and
melanoma-derived cells. The MTT cell viability assay
showed an IC50 of 2.4 mM in HT-144 cells. Thus, all of
the experiments were performed using two cinnamic
acid concentrations: 0.4 mM and 3.2 mM, which are
below and above the IC50, respectively. The NGM cell
line was more resistant to the treatment. The IC50 in the
NGM cells was not reached (even at 3.2 mM cinnamic
acid), and the cell growth was very similar among the
different treatment groups compared to the control
cells.
We did not observe differences between the control
using 1% ethanol and the control using only free
medium. Other experiments repeated this result. So,
from here on, we will mention only the control with free
medium.
Cell cycle analysis
The effect of cinnamic acid on cell viability may be a result
of cell cycle phase-specific arrest or cell death induction.
DNA quantification was performed using flow cytometry
and showed a decreased percentage in S phase in HT-144
cells treated with 3.2 mM cinnamic acid (16.08% to 6.35%)
and an increased frequency of hypodiploid cells after
treatment with the same concentration (from 13.80% in
the control group to 25.78% in the 3.2 mM group)
(Table 1). These data showed that the drug, at the highest
concentration, induced cell death in HT-144 cells and de-
creased the percentage of cells in S phase.
NGM cells showed few differences compared to the
melanoma cells. We did not observe a significant reduc-
tion in the percentage of cells in S phase. In contrast,
NGM cells showed a decreased percentage of cells in
G0/G1 after treatment with 3.2 mM cinnamic acid (from
64.81% in the control group to 40.46% in the treated
group). We also detected changes in the percentage of
hypodiploid cells (11.25% in the control group and
43.31% in the group treated with 3.2 mM of the drug).
S-phase was further analyzed in the BrdU incorpor-
ation experiments. The incorporation time periods were
1 h and 3 h in NGM cells and 1 h in HT144. A time
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interval of 3 hours was tested in the NGM cells because
of their slower proliferation rate (data obtained by
growth curves). In addition, the BrdU incorporation ex-
periments showed a significant reduction in the percent-
ages of cells in S phase in both cell lines after treatment
with 3.2 mM cinnamic acid (Figure 1). However, we
found no differences between the periods of incorpor-
ation (Figure 1). The reduction in the percentage of cells
in S phase was more significant in HT-144 cells than in
NGM cells. In these cells, the BrdU incorporation index
decreased from 22% in the control group to 0% in the
group treated with 3.2 mM cinnamic acid (Figure 1).
We also used a 0.05 mM cinnamic acid concentration
along the study; however we did not find changes in
comparison to the control group.
Cell death detection
The interference of cinnamic acid in the cell cycle may
result in cell death. To confirm this hypothesis, the cells
were labeled with M30. The HT-144 cell line showed an
increased frequency in labeled cells after 24 h of treat-
ment with both concentrations of the drug and this in-
crease was time-dependent (Table 2).
The activated-caspase 9 assay confirmed the data
obtained from the M30 labeling of HT-144 cells
(Figure 2). Because we could not analyze the cell death
in the NGM cell line using M30 labeling, we performed
the active-caspase 9 assay in NGM cells (Figure 3) to
compare the effects of cinnamic acid in both cell lines.
Cells exposed to ultraviolet radiation for 1 minute were
used as a positive control. This experiment verified that
both cell lines could functionally activate the caspase
cascade during the cell death process.
We did not observe significant differences between the
control and treated groups after 6 or 12 hours of drug
exposure (Table 3). Interestingly, the apoptotic cascade
in the HT-144 cells was initiated approximately 24 hours
after treatment with 3.2 mM cinnamic acid, specifically,
when the frequency of cell death changed from 5% in
the control group to 30% in the treated group. Our re-
sults indicated that there was no significant increase in
apoptotic cell frequency after treatment with 0.4 mM of
the drug.
Furthermore, there were no differences between the
control and treated groups of NGM cells after 24 hours
of treatment with cinnamic acid (Table 3). The fre-
quency of apoptotic cells in the control group was ap-
proximately 5%, and the frequency of apoptosis in the
NGM cell line did not reach 9% in any group. The statis-
tics confirmed that the differences observed were not
significant.
The western blotting analysis showed that both cell
lines express the p53 protein. We could not confirm the
selective effects of cinnamic acid by the total p53 quanti-
fication or p53 phosphorylation because apoptosis in
HT-144 cells was not directly associated with the in-
crease of p53 expression or phosphorylation (Figure 4).
Cell morphology
The morphological changes observed using microscopy
after treatment with cinnamic acid and the BrdU incorp-
oration data suggested that the drug targets the cell
Table 1 Effect of cinnamic acid on cell cycle of HT-144
and NGM cells after 48 h exposure
Cell
line
Cell cycle
phases
Control
groups
Treated groups
0.4 mM 3.2 mM
HT-144 Hypodiploid cells 13.80 ± 3.49 15.38 ± 0.86 25.78 ± 2.85a
G0/G1 phases 42.90 ± 4.37 45.12 ± 2.32 47.99 ± 5.30
S phase 16.08 ± 2,49 12.22 ± 2.01 6.35 ± 1.21b
G2/M phases 18.69 ± 4.10 19.95 ± 1.95 15.07 ± 2.04
Polyploid cells 9.16 ± 3.14 7.80 ± 2.43 5.19 ± 1.84
NGM Hypodiploid cells 11.25 ± 3.88 8.51 ± 3.10 43.31 ± 5.46b
G0/G1 phases 64.81 ± 3.43 64.72 ± 7.43 40.46 ± 3.94b
S phase 5.59 ± 1.56 4.48 ± 1.43 2.24 ± 1.01
G2/M phases 13.67 ± 1.43 16.82 ± 2.36 10.93 ± 3.65
Polyploid cells 4.93 ± 1.45 5.70 ± 1.27 3.21 ± 1.46
The numbers represent the frequency of cells (%) in each phase of the cell
cycle according to DNA quantification by flow cytometry. Results are showed
as Mean ± SD.
a Significantly different (p≤0.01) from control group and 0.4 mM
treated group.
b Significantly different (p≤0.05) from control group.
Figure 1 BrdU incorporation in NGM and HT-144 cells treated
with cinnamic acid. The cells incorporate BrdU for different periods
after 48 hours of treatment with two concentrations of cinnamic
acid. We observed significative effects of cinnamic acid on DNA
synthesis only in cells treated with 3.2 mM of the drug.
Bars = standard error.
Table 2 Frequency of HT-144 cells positive for M30 (%)
after treatment with cinnamic acid
Time of treatment Control 0.4 mM 3.2 mM
24 hours 0.80 ± 0.07 5.00 ± 0.09a 7.30 ± 1.02a
48 hours 1.20 ± 0.06 12.30 ± 1.95a 27.03 ± 2.36a
Results are showed as Mean ± SD.
a Significantly different (p≤0.05) vs control group.
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cycle. Thus, we analyzed the cytoskeleton of the cells
after drug treatment. The control groups of both cell lines
commonly appeared as fusiform cells, with microfilaments
that formed parallel stress fibers (Figures 5A-C, 6). After
treatment with 0.4 mM cinnamic acid, the HT-144
cells showed a triangular or stellate morphology, and an
altered orientation of actin filaments. The microfilament
disorganization was higher in the melanoma cells after
treatment with 3.2 mM of the drug (Figure 5D-F). We
detected important decrease in the microfilament density
in the peripheral cytoplasm and an accumulation of
fragmented F-actin near the nucleus in HT-144 cells
treated with the higher drug concentration.
We also observed microtubule disruption in HT-144
cells after treatment with cinnamic acid. Cells treated
with 0.4 mM cinnamic acid maintained a normal distri-
bution of microtubules, whereas treatment with 3.2 mM
induced very diffuse labeling in the cytoplasm with accu-
mulation around the cell nuclei (Figure 7).
Treatment with 3.2 mM cinnamic acid induced robust
morphological changes in some NGM cells. In addition
to changes that occurred in less than 2% of the cases, a
cytoskeletal analysis revealed the presence of coiled actin
filaments and microtubules (Figure 8). Moreover, the nu-
clei exhibited an alteration in their morphology, which
were observed in NGM cells that were treated with
3.2 mM cinnamic acid; however, a low frequency was
observed when compared to HT-144 cells. There was no
cytoskeleton reorganization in the NGM cells treated
with 0.4 mM of the drug.
To determine if there was an association between the
morphological changes and apoptosis, we subjected the
HT-144 cells to M30 and tubulin labeling simultan-
eously. The cells exhibited intact microtubules and M30
(+) (Figure 9A-B), microtubule disruption and M30(+)
(Figure 9C) and microtubule disruption and M30(–)
(Figure 9D). Thus, the apoptotic process and micro-
tubule disorganization are independent events in this
model system.
Nuclear aberrations
Because changes in apoptotic frequencies could be caused
by direct DNA breakage or chromosomal loss due to
microtubule disruption, we searched for cells with nuclear
alterations to evaluate the genotoxic potential of cinnamic
acid and analyzed the micronuclei frequency in HT-144
and NGM cells. The HT-144 control group showed 1.97%
micronucleated cells. Both cinnamic acid concentrations
increased the frequencies of the micronucleated cells:
3.13% with 0.4 mM and 6.07% with 3.2 mM cinnamic acid
(Table 4).
Figure 2 Activated-caspase 9 assay to cell death analysis on HT-144 cells. The activated-caspase 9 kit (GE Healthcare) was used to detect
different stages of cell death. The cells were treated at 0.4 or 3.2 mM cinnamic acid for 6 (A, B, C), 12 (D, E,F) and 24 hours (G, H, I). We can
observe increased frequency of apoptotic cells after 24 h of treatment at 3.2 mM cinnamic acid.
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The frequencies of the binucleated cells also increased
when the cells were treated with both drug concentrations:
from 1.83% in the control cells to 4.23% and 5.87% after
treatment with 0.4 mM and 3.2 mM cinnamic acid, re-
spectively. The frequency of cells with nuclear buds and
multinucleated cells were also higher in the treated group
compared to the control group; however, the effects were
milder, and a significant difference was observed in only
the group treated with 3.2 mM cinnamic acid. The fre-
quency of cells with nuclear buds increased from 0.2% to
1.3% in the control group after treatment. Moreover, the
presence of multinucleated cells increased from 0.43% to
1.17% in the control group after treatment.
NGM cells also showed an increased frequency in the
presence of cells with micronuclei and/or nuclear buds
after treatment with cinnamic acid. However, our results
demonstrated milder effects in this cell line (Table 4). The
control group showed a basal rate of micronucleated cells
of 1.38%, while the group treated with 3.2 mM cinnamic
Table 3 Frequencies (%) of apoptotic cells (early + late
apoptosis) in HT-144 and NGM cell lines after treatment
with cinnamic acid in different times and concentrations
Cell
line
Time of
treatment
Control
groups
Treated groups
0.05 mM 0.4 mM 3.2 mM
HT-144 6 hours 7.48 6.96 5.74 6.45
12 hours 2.78 2.29 2.77 7.20
24 hours 4.51 4.52 3.16 29.53a
NGM 6 hours 9.59 8.83 7.07 6.64
12 hours 4.44 4.46 2.97 2.92
24 hours 3.75 4.64 3.90 5.82
The results were obtained by quantification of cells positive to activated-
caspase 09 by using a flow cytometer.
a Significantly different from control group according to Multidimensional
Nonlinear Descriptive Analysis.
Figure 4 p53 and phospho-p53 levels in NGM and HT-144 cells
after cinnamic acid exposure for 24 hours. There were no
differences in p53 or phospho-p53 levels after treatment of NGM
cells. HT-144 cells showed decreased level of p53 and phospho-p53
after treatment with cinnamic acid. Tubulin was used as a
loading control.
Figure 3 Activated-caspase 9 assay to cell death analysis on NGM cells. The activated-caspase 9 kit (GE Healthcare) was used to detect
different stages of cell death. The cells were treated at 0.4 or 3.2 mM cinnamic acid for 6 (A, B, C), 12 (D, E, F) and 24 hours (G, H, I). The results
did not show differences among the control groups and the treated groups.
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acid exhibited an increase in frequency to 3.07%. However,
we could not detect alterations using other concentrations.
The frequency of cells with nuclear buds was also higher
after treatment with 3.2 mM cinnamic acid (0.15% in the
control group and 0.44% in the treated group); however,
this was not observed when using other concentrations.
Discussion
The decreasing effect of cinnamic acid on HT-144 cell
viability was consistent with previous studies. Liu et al.
[5] found that cinnamic acid reduced cell proliferation
of glioblastoma, melanoma, prostate and lung carcinoma
cells by 50% at concentrations between 1.0 and 4.5 mM.
Using a different drug treatment regime, Ekmekcioglu
et al. [41] showed that the IC50 of cinnamic acid was be-
tween 4.0 and 5.0 mM in Caco-2 cells.
Previous in vivo studies indicated that acute lethal
doses (LD50) of cinnamic acid was achieved at 160-220
mg/kg (ip) in mice, 2.5 g/kg (oral) in rats and 5 g/kg
(dermal) in rabbits. Thus, cinnamic acid exhibits a low
toxicity [42]. Other studies have shown that caffeic acid
phenethyl ester (cinnamic acid-derivative) exhibits a
cytotoxic activity in different oral carcinoma cells [43]
and that cinnamic acid protects DNA against fragmenta-
tion caused by hydrogen peroxide in V79 cells [44].
We could not determine the IC50 in NGM cells, des-
pite treatment with the highest drug concentration
(3.2 mM). Because cinnamic acid showed preferential
activity against cancer cells, it is important to identify
safe drug concentrations for use in vivo against cancer.
The IC50 value can change according to the cell type,
and it can reach 20.0 mM in fibroblasts [5]. This
variation may be related to the cell type. Lee et al. [8]
demonstrated that dietary compounds with antioxidant
properties, such as polyphenols in green tea, can activate
the MAPK pathway. They suggested that the tumor sup-
pressor protein p53 and p38 MAPK are involved in the
apoptotic process of tumor cells. Nevertheless, these sub-
stances, when used at high concentrations, can activate the
caspase cascade and induces apoptosis in normal cells [8].
Thus, it is important to comprehend the action of these
drugs at different concentrations in different systems to
confirm its preferential activity against a target cell type.
Drugs that cause DNA breakage commonly result in
cell cycle arrest and the activation of apoptosis [40]. Sev-
eral of these drugs cause nuclear alterations by disrup-
tion of cytoskeletal organization. Microtubule disruption
could also cause G2/M arrest prior to inducing cell
death by apoptosis [45,46]. Thus, we investigated the
cytoskeletal patterns of cells that were treated with
cinnamic acid.
The control group showed a microtubule network that
was very finely departed from the centrosome region
near the nucleus. A visible disorganization of the tubulin
filaments was detected in interphasic treated cells. Cells
treated with 3.2 mM cinnamic acid showed diffuse cyto-
plasmic staining and protein accumulation around the
nucleus. Cells treated with a 0.4 mM dose of the drug
did not demonstrate alterations in the organization of
their microtubule cytoskeleton.
Cytoplasmic retraction [47,48] is a characteristic of
apoptosis, and cytoskeletal disorders have been impli-
cated in this process [49]. Actin cleavage has been as-
sociated with many characteristics of pre-apoptotic
Figure 5 Effects of cinnamic acid on microfilaments organization of HT-144 cells. Images obtained by Laser Scanning Confocal Microscopy
of phalloidin FITC-conjugated staining (green) preparations: A,B,C) HT-144 control cells; D,E,F) HT-144 cells treated with 3.2 mM cinnamic acid.
DNA was counterstained with propidium iodide (red). Note the stress fiber formation in control cells (above) and the decreasing of peripheral
actin filaments and perinuclear accumulation of F-actin in treated groups (below).
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cells [50], and microfilament reorganization is essential
to apoptotic body formation in later stages of cell
death [47].
The morphological changes observed in these cells re-
vealed an association with actin filament depolymerization.
Similar effects were shown in studies conducted by Boggio
et al. [51], which demonstrated that human fibroblasts
from keloids treated with verapamil, a calcium antagonist,
showed an altered bipolar to spherical morphology. Boggio
et al. [51] showed disassembly of the actin network with
the formation of shorter stress fibers in fibroblasts treated
with verapamil. This was strongly associated with a change
in cell morphology.
The treatment of cells using anti-mitotic agents, such as
taxol and taxotere, which maintain tubulin polymerization,
revealed interesting alterations in the actin cytoskeleton. In
these studies, MCF7 cells were treated with taxol or
taxotere at concentrations of 10 μM or higher, which
resulted in a decrease in peripheral microfilaments and
progressive cytoplasmic actin accumulation and actin rings
Figure 6 Cytoskeleton organization in NGM control cells. F-actin (green) was stained with phalloidin FITC-conjugated. Microtubules (blue)
were labeled with anti-α and β tubulin and secondary antibody CY-5-conjugated. DNA was counterstained with propidium iodide (red). Note the
stress fiber formation (actin filaments). The cells showed a microtubule network that was very finely departed from the centrosome region near
the nucleus. We can also observe a mitotic cell (right column). The images were obtained by Laser Scanning Confocal Microscopy.
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around the nuclei [52]. We demonstrated that the effects
of cinnamic acid on the actin cytoskeleton in our model
system were similar to those observed in other systems
using different drugs. Cells treated with 3.2 mM cinnamic
acid showed a sharp reduction in peripheral microfila-
ments, which was in contrast with many strongly stained
clusters of F-actin located around the nuclei.
Cytoskeletal damage is a characteristic of pre-apoptotic
cells [50]. Mills et al. [53] demonstrated cytoskeletal alter-
ations during apoptosis and suggested a rearrangement of
the peripheral actin ring in the cell. During bleb forma-
tion, actin and myosin filaments slide over each other,
resulting in contraction of the cell border toward the cen-
ter. This process impairs the binding of actin filaments to
the cell membrane.
The mechanism by which cinnamic acid causes micro-
filament disorganization is not well understood; however,
because taxol does not exhibit direct effects on microfil-
aments, this suggests interdependency between actin fil-
aments and microtubules [52].
The disorganization of microtubules in cells treated with
cinnamic acid may be directly caused by impairment in the
tubulin molecules or indirectly by an alteration in the mole-
cules associated with microtubule polymerization. It is
known that the dynamic equilibrium of tubulin may be al-
tered at high concentrations of free cytosolic calcium
(higher than 10-7 M), which results in the depolymerization
of microtubules [54].
Studies using other natural compounds have shown
that the induction of cell death by caffeic acid and
curcumin in HL-60 cells [8] and L929 mouse fibroblasts
(Thayyllathil at al., 2008), respectively, is associated with
mitochondrial disruption, which may be due to an aug-
mented concentration of calcium that results in cyto-
skeletal disruption. These results are similar to the
observations found in our system.
Our results allow us to affirm that microtubule
depolymerization, as well as microfilament disorganization,
occurred after exposure to 3.2 mM cinnamic acid. Micro-
tubule disruptions have been previously described as a trig-
ger of the apoptotic pathway, which eventually results in
cell death [54].
Our data suggest that there is no relationship between
the effects of cinnamic acid on cytoskeletal elements and
Figure 7 Effects of cinnamic acid on microtubules organization of HT-144 cells. Images obtained by Laser Scanning Confocal Microscopy of
anti-tubulin immunofluorescence (blue) preparations: A) interphasic HT-144 control cells; B) mitotic HT-144 control cell; C,D) HT-144 cells treated
with 3.2 mM cinnamic acid. DNA was counterstained with propidium iodide (red). We can observe cells with a microtubule network that was
very finely departed from the centrosome region near the nucleus (up left) and a normal mitosis (up right). On the other hand, we found cells
with microtubule disorganization and tubulin bunches near the nuclei.
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apoptotic induction. We have demonstrated that M30
staining and microtubule disorganization are, at least in
part, independent events.
Caffeic acid, another cinnamamide compound, causes
apoptosis in HL-60 cells via mitochondrial dysfunction [8].
Previous studies have shown a relationship between cancer
chemotherapeutic agents targeting microtubules and apop-
tosis [55,56]. The flow cytometry assay did not show G2/M
arrest; however, microtubule disorganization was caused by
cinnamic acid treatment. Thus, the apoptotic events ob-
served in our study were not caused by cytoskeletal
reorganization. Tseng et al. [57] studied podophylotoxin
and suggested that mitotic arrest is not a prerequisite for
apoptosis, although they often can occur concomitantly.
The present data suggest that microtubule disorganization
after cinnamic acid exposure is dependent on the drug con-
centration. In our system, cytoskeletal disorganization is
mainly responsible for the formation of nuclear aberrations.
Figure 8 Cytoskeleton organization in NGM cells treated with 3.2 mM cinnamic acid. The cells were treated with the drug for 48 hours.
F-actin (green) was stained with phalloidin FITC-conjugated. Microtubules (blue) were labeled with anti-α and β tubulin and secondary antibody
CY-5-conjugated. DNA was counterstained with propidium iodide (red). The images were obtained by Laser Scanning Confocal Microscopy. Note
that there are cells with normal cytoskeletal organization (left column) and cells with drastic morphological changes (intermediate and
right columns).
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We clearly observed apoptotic HT-144 cells, as
assessed by phosphorylated cytokeratin 18. The M30
antibody stains cells in early apoptosis. In the present
study, we showed that the apoptotic process initiates
after 24 hours of treatment and that these effects were
dependent on drug concentration, indicating that longer
treatments with cinnamic acid could elicit a more robust
response in cell viability.
M30 staining was not observed in NGM cells inde-
pendent of the treatment. Cytokeratin 18 is usually
found in the epithelial cells and is not expressed in nor-
mal melanocytes; however, some studies have associated
its presence in melanoma cells with a worse prognosis
[58,59]. The HT-144 cells were positive for phospho-
cytokeratin 18 after treatment with cinnamic acid. These
data further characterize the HT-144 cell line and show
Figure 9 M30 and tubulin labeling in HT-144 cells. HT-144 cells were treated with 0.4 or 3.2 mM cinnamic acid for 24 or 48 hours.
Fragmented cytokeratin 18 (green) were labeled with M30 antibody FITC and microtubules (blue) were labeled with anti-α and β tubulin and
secondary antibody TRITC-conjugated. A,B) cells with intact microtubules and M30(+); C) cells with microtubule disruption and M30(+); D) cells
with microtubule disruption and M30(–). Arrows = M30 staining. The results demonstrate that cell death and microtubule disorganization are
independent events in our system. The images were obtained by Laser Scanning Confocal Microscopy.
Table 4 Effect of cinnamic acid on formation of nuclear aberrations in NGM and HT-144 cells after 48 h exposure
Cell line Group Micronucleated cells Cells with nuclear buds Binucleated cells Multinucleated cells
HT-144 Control 1.97 ± 0.04 0.20 ± 0.05 1.83 ± 0.02 0.43 ± 0.06
0.05 mM 2.01 ± 0.06 0.24 ± 0.06 1.79 ± 0.04 0.52 ± 0.03
0.40 mM 3.13 ± 1.03a 0.40 ± 0.02 4.23 ± 1.03a 0.67 ± 0.04
3.20 mM 6.07 ± 1.45b 1.30 ± 0.02b 5.87 ± 0.98a 1.17 ± 0.12a
NGM Control 1.38 ± 0.06 0.15 ± 0.01 0.20 ± 0.03 0.05 ± 0.02
0.05 mM 1.27 ± 0.04 0.19 ± 0.04 0.29 ± 0.02 0.25 ± 0.08
0.40 mM 1.15 ± 0.01 0.10 ± 0.03 0.37 ± 0.07 0.00 ± 0.00
3.20 mM 3.07 ± 0.03a 0.44 ± 0.02a 0.53 ± 0.06 0.00 ± 0.00
The numbers represent the frequency of cells (%) with nuclear alterations. Results are showed as Mean ± SD.
a Significantly higher (p ≤ 0.05) than control group.
b Significantly higher (p ≤ 0.05) than control group, group treated with 0.05 mM and group treated with 0.4 mM cinnamic acid.
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significant differences between the cell lines, providing
new information regarding the HT-144 cell line.
Quantification of picnotic and fragmented nuclei
showed that less than 1% of cells were apoptotic cells
(data not shown). This could occur because many apop-
totic cells are in suspension. Thus, we used flow cytome-
try to ensure that all of the cells would be quantified.
The annexin-V assay did not reveal any differences
among the groups of cells, except in groups of cells that
were treated for long time periods. This result allowed
us to infer that phosphatidylserine could not be exposed
in our system during early cell death.
Caspase 9 is an initiator caspase that is usually associ-
ated with the activation of effector caspases, including
caspase 3 and caspase 7 [60,61]. The activation of
caspase 9 confirmed the results obtained by M30 stain-
ing in HT-144 cells and showed that cell apoptosis was
induced after 24 hours of treatment with cinnamic acid.
NGM cells were resistant to the treatment.
Several studies have demonstrated the antioxidant ac-
tivity of similar compounds such as caffeic acid and de-
rivatives [14,15]. This antioxidant activity was associated
with the induction of the cell death process according to
Lee et al. [8]. This authors showed that treatment with
caffeic acid activated the MAPK cascade, including p38
MAPK, which phosphorylated p53 [62,63] in the human
leukemia cell line HL-60. However, contrary to other
malignancies, studies have failed to associate anticancer
potential of some agents with p53 activity in melanoma,
and our results showed decreased p53 expression and
phosphorylation in HT-144 cells treated with cinnamic
acid. So, we could not establish a relation between apop-
tosis and p53 phosphorylation in our system.
Many natural compounds with cytotoxic activity can
cause nuclear alterations by disrupting cell separation
during mitotic process. These disruptions result in the
initiation of an aneugenic pathway [32,33,64]. According
to Efthimiou et al. [33], the aneugenic potential is one
event that can result in the carcinogenic process. Thus,
an important aspect to be evaluated in the study of nat-
ural products is their genotoxic potential.
Chen et al. [65] showed that micronuclei may be pro-
duced by chromosomal breakage and/or whole chromo-
somal loss. In our studies, even at 0.4 mM cinnamic acid,
an increase in the frequency of micronucleated cells was
observed. The higher frequencies of micronucleated cells
in NGM and HT-144 cells treated with cinnamic acid re-
vealed genotoxic activity.
Treatment with cinnamic acid efficiently decreased HT-
144 melanoma cell viability in culture at a concentration of
3.2 mM. Our study demonstrates that the antiproliferative
activity of the drug is associated with caspase 9 activation,
but not p53 phosphorylation, after 24 h treatment. We
showed that HT-144 cells presented phospho-cytokeratin
18 and that the M30 staining was efficient in detecting
early apoptosis in this cell line. Cinnamic acid showed
genotoxic potential at both tested concentrations, inducing
the formation of micronucleated cells. This activity was, at
least in part, a consequence of cytoskeletal disorganization.
Thus, despite the genotoxic effects observed, the anti-
proliferative activity of cinnamic acid at a concentration of
3.2 mM in melanoma cells suggests its potential use as an
adjuvant in melanoma therapy.
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